Publications

2007

Roblin P., Guillet V., Joubert O., Keller D., Erard M., Maveyraud L., Prévost G. and Mourey L. (2007). A covalent S-F heterodimer of leucotoxin reveals molecular plasticity of beta-barrel pore-forming toxins. Proteins (Structure, Function, and Bioinformatics); in press. 

Alazard R., Mourey L., Ebel C., Konarev P. V., Petoukhov M. V., Svergun D. I. and Erard M. (2007). Fine-tuning of intrinsic N-Oct-3 POU domain allostery by regulatory DNA targets. Nucleic Acids Res., 35(13), 4420-32. 

Bessière D., Lacroix C., Campagne S., Ecochard V., Guillet V., Mourey L., Lopez F., Czaplicki J., Demange P., Milon A., Girard J.P. and Gervais V. (2007). Structure-function analysis of the THAP-Zinc finger of THAP1, a large C2CH DNA-Binding module linked to RB/E2F pathways. J. Biol. Chem., accepté. 

Joubert O., Voegelin J., Guillet V., Tranier S., Werner S., Colin D.A., Serra M.D., Keller D., Monteil H., Mourey L. and Prevost G. (2007). Distinction between Pore Assembly by Staphylococcal alpha-Toxin versus Leukotoxins. J. Biomed. Biotechnol., 2007, 25935.

2006

Prévost, G., Mourey, L., Colin, D. A., Monteil, H., Dalla Serra, M. & Menestrina, G. (2005). Alpha-helix and beta-barrel pore-forming toxins (leucocidins, alpha-, gamma- and delta-cytolysins) of Staphylococcus aureus. In : The Comprehensive Sourcebook of Bacterial Protein Toxins (Alouf, J. & Popoff, M. R., Eds), Third Edition, 588-605, Academic Press (London)

Boissier, F., Bardou, F., Guillet, V., Uttenweiler-Joseph, S., Daffé, M., Quémard, A. & Mourey, L. (2006). Further insight into S-adenosylmethionine-dependent methyltransferases: structural characterization of Hma, an enzyme essential for the biosynthesis of oxygenated mycolic acids in Mycobacterium tuberculosis. J Biol Chem., 281(7), 4434-45.

Garcia-Alles L.F., Versluis K., Maveyraud L., Vallina A.T., Sansano S., Bello N.F., Gober H.J., Guillet V., De la Salle H., Puzo G., Mori L., Heck A., De Libero G. and Mourey L. (2006). Endogenous phosphatidylcholine and a long spacer ligand stabilize the lipid-binding groove of CD1b. EMBO J., 25, 3684-3692.

 Joubert O., Viero G., Keller D., Martinez E., Colin D.A., Monteil H., Mourey L., Dalla Serra M. and Prevost G. (2006). Engineered covalent leucotoxin heterodimers form functional pores : insights into S-F interactions. Biochem J., 396, 381-389.

 Joubert O., Guillet V., Viero G., Colin D. A., Roblin P., Comai M., Potrich C., Corraiola M., Martinez E., Keller D., Monteil H., Dalla Serra M., Mourey L. and Prévost G. (2006). Staphylococcal leucotoxins : Tribute to Gianfranco Menestrina to their study. Int. J. Med. Microbiol., sous presse.

2005

De la Salle H, Mariotti S, Angenieux C, Gilleron M, Garcia-Alles LF, Malm D, Berg T, Paoletti S, Maitre B, Mourey L, Salamero J, Cazenave JP, Hanau D, Mori L, Puzo G, De Libero G.(2005). Assistance of microbial glycolipid antigen processing by CD1e. Science, 310(5752),1321-4.

Joubert, O., Potrich, C., Guillet, V., Mourey, L., Roblin, P., Keller, D., Viero, G., Forestier, E., Martinez, E., Baba Moussa, L., Monteil, H., Colin, D. A., Dalla Serra, M. & Prévost, G. (2005). Les leucotoxines de staphylocoques : de l'investigation bio-structurale vers la notion d'inhibiteurs. In : Toxines et douleur (Bon, C. et al., Eds), 75-84, Editions Lavoisier, Paris (France)

2004

Guillet, V., Roblin, P., Werner, S., Coraiola, M., Menestrina, G., Monteil, H., Prévost, G. & Mourey, L. (2004). Crystal structure of leucotoxin S component : new insight into the staphylococcal -barrel pore-forming toxins. J. Biol. Chem. 279, 41028-37

Guillet, V., Keller, D., Prévost, G. & Mourey, L. (2004). Crystallization and preliminary crystallographic data of a leucotoxin S component from Staphylococcus aureus. Acta Crystallogr D60, 310-3

Veyron-Churlet, R., Guerrini, O., Mourey, L., Daffé, D. & Zerbib, D. (2004). Protein-protein interactions within the Fatty Acid Synthase-II system of Mycobacterium tuberculosis are essential for mycobacterial viability. Mol Microbiol 54, 1161-72

Monferran, S., Muller, C., Mourey, L., Frit, P. & Salles, B. (2004). The membrane-associated form of the DNA repair protein Ku is involved in cell adhesion to fibronectin. J. Mol. Biol. 337, 503-11

Howard E.I., Sanishvili R.,Cachau R.E., Mitschler A., Chevrier B., Barth P., Lamour V., Van Zandt M., Sibley E., Bon C., Moras D., Schneider T. R., Joachimiak A. & Podjarny A. (2004). Ultra-high resolution drug design I : details of interactions in human Aldose Reductase-Inhibitor Complex at 0.66 A. Proteins : Structure, Function and Bioinformatics, 55, 792-804.

2003

Alazard R., Mourey L., Konarev P., Svergun D. and Erard M. (2003). SAXS analysis of the N-Oct3 - CRH promoter interactions, (2003) Hamburg Synchrotron Laboratory Annual Report.

2002

Cabantous S., Guillet V., Ohta N., Newton A. and Samama J.P. (2002). Characterization and crystallization of DivK, an essential response regulator for cell division and differentiation in Caulobacter crescentus. Acta Crystallogr. D Biol. Crystallogr., 58, 1249-1251.

Guillet V., Ohta N., Cabantous S., Newton A. and Samama J.P. (2002). Crystallographic and biochemical studies of DivK reveal novel features of an essential response regulator in Caulobacter crescentus. J. Biol. Chem., 277, 42003-42010.

Maveyraud L., Golemi D., Ishiwata A., Maroueh O., Mobashery S. and Samama J.P. (2002). High resolution X-ray structure of an acyl-enzyme species for the class D beta-lactamase. J. Am. Chem. Soc., 124, 2461-2465.

Meroueh S.O., Roblin P., Golemi D., Maveyraud L., Vakulenko S.B., Zhang Y., Samama J.P. and Mobashery S. (2002). Molecular dynamics at the root of expansion of function in the M69L inhibitor-resistant TEM beta-lactamase from Escherichia coli. J. Am. Chem. Soc., 124, 9422-9430.

Sougakoff W., L'Hermite G., Pernot L., Naas T., Guillet V., Nordmann P., Jarlier V. and Delettre J. (2002). Structure of the imipenem-hydrolyzing class A beta-lactamase SME-1 from Serratia marcescens. Acta Crystallogr., D58, 267-274.

Golemi D., Maveyraud L., Haddad J., Lee W., Ishiwata A., Miyashita K., Mourey L., Vakulenko S., Kotra L.P., Samama J.P. and Mobashery S. (2002). Antibacterials as wonder drugs and how their effectiveness is beeing compromised. Trends in Drug Research III,Van der Goot H. Ed, vol 32, 65-71.